Phase Inks Agreement with DPT Labs for Clinical Supplies before a planned Phase 3 studies for its Topical ketoprofen-based.[ Professional Services Close – Up]tree concludes: We are very confident that the election DPT Labs will Imprimis produce with the best semi-solid manufacturing capacity in the United States and the flexibility of the scale Impracor is the DPT agreement means that Imprimis a step. A step closer to our goal of getting Impracor approved for sale and in the hands of patients suffering with musculoskeletal pain and inflammatory diseases, ..

Imprimis Pharmaceuticals, a specialty pharmaceutical company focused on the development focused on the development of non-invasive, topically delivered products. Imprimis Pharmaceuticals Inks agreement with DPT Labs for Clinical Supplies before a planned phase 3 trials for its ketoprofen-Based topical Anti-Inflammatory drug.Examples medicines that are tested by the pediatric exclusivity for the marking labeling change belong more than one dozen – among antiseizure medicines and some psychiatric drugs. A useful tool adjustment for use in children for Benjamin.